Estimated HPV-Attributable Inpatient Pharmaceutical Reimbursement in Bulgaria, 2021–2025: A National Payer-Perspective Expenditure Analysis

Kostadin Kostadinov, Victoria Mandova, Vanya Rangelova, Ani Kevorkyan, Ralitsa Raycheva

Open source

DOI
10.3390/healthcare14162474
Published
2026-08-10
Container
Healthcare
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/healthcare14162474,
  title = {Estimated HPV-Attributable Inpatient Pharmaceutical Reimbursement in Bulgaria, 2021–2025: A National Payer-Perspective Expenditure Analysis},
  author = {Kostadin Kostadinov and Victoria Mandova and Vanya Rangelova and Ani Kevorkyan and Ralitsa Raycheva},
  year = {2026},
  journal = {Healthcare},
  doi = {10.3390/healthcare14162474},
  url = {https://doi.org/10.3390/healthcare14162474}
}

RIS

TY  - JOUR
TI  - Estimated HPV-Attributable Inpatient Pharmaceutical Reimbursement in Bulgaria, 2021–2025: A National Payer-Perspective Expenditure Analysis
AU  - Kostadin Kostadinov
AU  - Victoria Mandova
AU  - Vanya Rangelova
AU  - Ani Kevorkyan
AU  - Ralitsa Raycheva
PY  - 2026
JO  - Healthcare
DO  - 10.3390/healthcare14162474
UR  - https://doi.org/10.3390/healthcare14162474
ER  - 

APA

Kostadinov, K., Mandova, V., Rangelova, V., Kevorkyan, A., & Raycheva, R. (2026). Estimated HPV-Attributable Inpatient Pharmaceutical Reimbursement in Bulgaria, 2021–2025: A National Payer-Perspective Expenditure Analysis. Healthcare. https://doi.org/10.3390/healthcare14162474

Source records